What puts heart failure patients at risk for poor medication adherence?

Patient Preference and Adherence

Volumn 8, Issue , 2014, Pages 1007-1018

  Knafl, George J ^a   Riegel, Barbara ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Heart failure; Medication adherence; Multiple chronic conditions; Risk factors; Self care; Sleep quality

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR SYSTEM EXAMINATION; COMORBIDITY; DATA COLLECTION METHOD; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; LIKELIHOOD CROSS VALIDATION SCORE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEDICATION EVENT MONITORING SYSTEM; POLYPHARMACY; RISK ASSESSMENT; SCORING SYSTEM; SELF CARE; SLEEP QUALITY; SOCIAL SUPPORT; WORLD HEALTH ORGANIZATION;

EID: 84904554097     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S64593     Document Type: Article

References (63)

1. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6-e245.
2. Herr JK, Salyer J, Lyon DE, Goodloe L, Schubert C, Clement DG. Heart Failure Symptom Relationships: A Systematic Review. J Cardiovasc Nurs. Epub 2013 Jul 8.
3. Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2(5): 407-413.
4. Heidenreich PA, Albert NM, Allen LA, et al; American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606-619.
5. Andrews RM, Elixhauser A. The national hospital bill: growth trends and 2005 update on the most expensive conditions by payer. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb42.pdf. Accessed April 18, 2014.
6. Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. 2012;126(4):501-506.
7. Riegel B, Knafl GJ. Electronically monitored medication adherence predicts hospitalization in heart failure patients. Patient Prefer Adherence. 2013;8:1-13.
8. Wu JR, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am. 2008;43(1):133-153.
9. World Health Organisation. Overview: Medication Adherence-Where Are We Today? World Health Organization; 2006. Available from: http://www.adultmeducation.com/downloads/Adult_Med_Overview.pdf. Accessed April 18, 2014.
10. Riegel B, Lee CS, Ratcliffe SJ, et al. Predictors of objectively measured medication nonadherence in adults with heart failure. Circ Heart Fail. 2012;5(4):430-436.
11. AlGhurair SA, Hughes CA, Simpson SH, Guirguis LM. A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model. J Clin Hypertens (Greenwich). 2012;14(12):877-886.
12. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 2004;4(3):191-195.
13. Riegel B, Moelter ST, Ratcliffe SJ, et al. Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure. J Card Fail. 2011;17(4):340-348.
14. Brandt J, Folstein MF. Telephone Interview for Cognitive Status. Odessa, FL: Psychological Assessment Resources, Inc; 2003.
15. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360(14):1418-1428.
16. Vrijens B, Tousset E, Rode R, Bertz R, Mayer S, Urquhart J. Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models. J Clin Pharmacol. 2005;45(4):461-467.
17. Savic RM, Barrail-Tran A, Duval X, et al; ANRS 134-COPHAR 3 Study Group. Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients. Clin Pharmacol Ther. 2012; 92(5):575-583.
18. McNabb JJ, Nicolau DP, Stoner JA, Ross J. Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS. 2003;17(12):1763-1767.
19. Cramer J, Vachon L, Desforges C, Sussman NM. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia. 1995;36(11):1111-1117.
20. Sutton S, Kinmonth AL, Hardeman W, et al. Does Electronic Monitoring Influence Adherence to Medication? Randomized Controlled Trial of Measurement Reactivity. Ann Behav Med. Epub 2014 Feb 27.
21. Lezak M, Howieson D, Lorig D. Neuropsychological Assessment. 4th ed. New York: Oxford University Press; 2004.
22. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5): 1245-1255.
23. Knafl GJ, Delucchi KL, Bova CA, Fennie KP, Ding K, Williams AB. A systematic approach for analyzing electronically monitored adherence data. In: Ekwall B, Cronquist M, editors. Micro Electro Mechanical Systems (MEMS) Technology, Fabrication Processes and Applications. Hauppauge, NY: Nova Science Publishers; 2010:1-66.
24. Knafl GJ, Bova CA, Fennie KP, O'Malley JP, Dieckhaus KD, Williams AB. An analysis of electronically monitored adherence to antiretroviral medications. AIDS Behav. 2010;14(4):755-768.
25. Delucchi KL, Knafl GJ, Haug N, Sorensen J. Adaptive Poisson modeling of medication adherence among HIV-positive methadone patients provided greater understanding of behavior. In: Ekwall B, Cronquist M, editors. Micro Electro Mechanical Systems (MEMS) Technology, Fabrication Processes and Applications. Hauppauge, NY: Nova Science Publishers; 2010:259-273.
26. Knafl GJ, Schoenthaler A, Ogedegbe G. Secondary analysis of electronically monitored medication adherence data for a cohort of hypertensive African-Americans. Patient Prefer Adherence. 2016:207-219.
27. Kroenke K, Spitzer R, Williams J. The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine. 2001; 16(9):606-613.
28. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons; 2000.
29. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-1310.
30. Kardas P. Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial. J Antimicrob Chemother. 2007;59(3):531-536. Epub 2007 Feb 8.
31. Mastromarino V, Casenghi M, Testa M, Gabriele E, Coluccia R, Rubattu S, Volpe M. Polypharmacy in heart failure patients. Curr Heart Fail Rep. 2014;11(2):212-219.
32. Jansà M, Hernández C, Vidal M, et al. Multidimensional analysis of treatment adherence in patients with multiple chronic conditions. A cross-sectional study in a tertiary hospital. Patient Educ Couns. 2010;81(2):161-168.
33. Dickson VV, Buck H, Riegel B. A qualitative meta-analysis of heart failure self-care practices among individuals with multiple comorbid conditions. J Card Fail. 2011;17(5):413-419.
34. Dickson VV, Buck H, Riegel B. Multiple comorbid conditions challenge heart failure self-care by decreasing self-efficacy. Nurs Res. 2013;62(1): 2-9.
35. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540-550.
36. Alfaro Lara ER, Vega Coca MD, Galván Banqueri M, et al. Selection of tools for reconciliation, compliance and appropriateness of treatment in patients with multiple chronic conditions. Eur J Intern Med. 2012;23(6):506-512.
37. Neupert SD, Patterson TR, Davis AA, Allaire JC. Age differences in daily predictors of forgetting to take medication: the importance of context and cognition. Exp Aging Res. 2011;37(4):435-448.
38. Quan SF, Chan CS, Dement WC, et al. The association between obstructive sleep apnea and neurocognitive performance-the Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep. 2011;34(3): 303B-314B.
39. McKenna BS, Dickinson DL, Orff HJ, Drummond SP. The effects of one night of sleep deprivation on known-risk and ambiguous-risk decisions. J Sleep Res. 2007;16(3):245-252.
40. Cameron J, Worrall-Carter L, Page K, Stewart S. Self-care behaviours and heart failure: does experience with symptoms really make a difference? Eur J Cardiovasc Nurs. 2010;9(2):92-100.
41. Francque-Frontiero L, Riegel B, Bennett J, et al. Self-care of persons with heart failure: Does experience make a difference? Clin Excel Nurse Pract. 2002;6:23-30.
42. Dickson VV, Deatrick JA, Riegel B. A typology of heart failure self-care management in non-elders. Eur J Cardiovasc Nurs. 2008;7(3): 171-181.
43. Vaduganathan M, Gheorghiade M, Butler J. Expanding the scope of the "polypill" to heart failure. J Card Fail. 2013;19(8):540-541.
44. Weaver TE, Chasens ER. Continuous positive airway pressure treatment for sleep apnea in older adults. Sleep Med Rev. 2007;11(2):99-111.
45. NIH State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults statement. NIH Consens State Sci Statements. 2005;22(2):1-30.
46. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF 3rd, Kupfer DJ. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA. 1997;278(24):2170-2177.
47. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep. 2003;26(7):793-799.
48. Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med. 2005;6(6):487-495.
49. Clarfield AM. Review: sedative-hypnotics increase adverse effects more than they improve sleep quality in older persons with insomnia. ACP J Club. 2006;145(1):14.
50. Curran HV, Collins R, Fletcher S, Kee SC, Woods B, Iliffe S. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med. 2003;33(7):1223-1237.
51. Mitchell MD, Gehrman P, Perlis M, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40.
52. Riegel B, Hanlon AL, Zhang X, et al. What is the best measure of daytime sleepiness in adults with heart failure? J Am Assoc Nurse Pract. 2013;25(5):272-279.
53. Gladsjo JA, Heaton RK, Palmer BW, Taylor MJ, Jeste DV. Use of oral reading to estimate premorbid intellectual and neuropsychological functioning. J Int Neuropsychol Soc. 1999;5(3):247-254.
54. Uttl B. North American Adult Reading Test: age norms, reliability, and validity. J Clin Exp Neuropsychol. 2002;24(8):1123-1137.
55. Dahlem NW, Zimet GD, Walker RR. The Multidimensional Scale of Perceived Social Support: a confirmation study. Journal of clinical psychology. 1991;47(6):756-761.
56. Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess. Winter 1990;55(3-4):610-617.
57. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373-383.
58. van der Wal M, Jaarsma T, Moser D, van Veldhuisen D. Development and testing of the Dutch Heart Failure Knowledge Scale. European Journal of Cardiovascular Nursing. August 2005.
59. Riegel B, Lee CS, Dickson VV, Carlson B. An Update on the Self-Care of Heart Failure Index. Journal of Cardiovascular Nursing. 2009; 24(6):485-497.
60. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15(4):376-381.
61. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10(4): 431-436.
62. Buysse D, Reynolds, CF 3d, Monk, TH, Berman, SR, Kupfer, DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatr Res. 1989;28:193-213.
63. Basner M, Dinges DF. Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. Sleep. 2011;34(5):581-591.